PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-12-13 (5)

Date Title Company
13-Dec-2025 U.S. FDA Approves NUZOLVENCE® (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents Businesswire